“To use or not to use the muscle” that is the question in the capsular contracture dilemma
Editorial Commentary

“To use or not to use the muscle” that is the question in the capsular contracture dilemma

Marco Bernini^

Breast Surgery, Breast Unit, Oncology Department, Careggi University Hospital, Florence, Italy

^ORCID: 0000-0002-9598-4860.

Correspondence to: Marco Bernini, MD, PhD. Breast Surgery, Breast Unit, Oncology Department, Careggi University Hospital L.go Brambilla 3, 50134 Florence, Italy. Email: marco.bern@tin.it.

Submitted Apr 10, 2021. Accepted for publication May 26, 2021.

doi: 10.21037/gs-21-237


Breast surgery is now facing an era of implant based breast reconstructions (IBBRs). In Europe IBBR is the most common choice in case of conservative mastectomy, sometimes comprising more than 90% of the reconstructions performed (1). In US as well, IBBR has been increasingly adopted in the last decades, reaching a rate of approximately 80% of all breast reconstructions (2). There are several reasons for this preference towards a prosthetic based approach, namely invasiveness, time, costs etc. (3). As the numbers rise several technical innovations are revolutionizing this field, with a relentless search of better functional and cosmetic outcomes. Nonetheless, IBBR is not always a pleasure cruise and, apart from early complications, there is a feared, unfortunately common, long-term pitfall: capsular contracture (CC).

CC is defined as an excessive fibrotic reaction to the implanted breast device, creating a thick capsule that causes discomfort, sometimes pain, and also a distortion of the reconstructed breast mound. A commonly used tool of evaluation is the 4-grade Baker scale, where the fourth grade represents a painful, hard and cosmetically awful reconstructed breast.

In literature several studies have reported an incidence of CC ranging from 0.6% to 19% in breast augmentation to 19–48% in breast reconstruction (4). More recent reports show a 10% rate in augmentation (5), while in IBBR the rate of this complication is estimated to be overall 9.8%, with the rate after post-mastectomy radiation therapy (PMRT) being 18.7%, and 7.5% for patients without PMRT (6).

All these rates, by the way, are flawed by the grade of Baker scale that is considered the threshold for CC (the vast majority of Authors consider only grade III and IV, but sometimes the adopted criterion is not reported, making a literature review very difficult), and mostly by the fact that such rating is always dependent on the visiting surgeon and not objectively measurable.

Several factors have been claimed to be the “culprit”: factors such as infection, biofilms, irradiation, hematoma and implant surface type. None of them, by the way, has ever been eventually identified as the “one”. But, some new developments in surgical techniques of IBBR might help us resolve this surgical conundrum.

In fact, a real revolution has changed the IBBR scenario in the last few years, the pre-pectoral approach. This novel technique has been having a sky-rocketing success, really changing the IBBR paradigm.

Among all the advantages of such a technique, there is, without any doubt, a striking long-term outcome of very low CC, trending towards 0% in many series, with an average value of approximately 5% form a recent meta-analysis (7). Two recent studies coherently found that CC is much higher in retro-pectoral cases rather than pre-pec ones (8,9). When considering pre-pec cases only, PMRT makes the difference, as shown in an interesting article on this topic, published on this journal (10), where CC is significantly different in pre-pec cases submitted to PMRT compared to those not submitted to it. Another study, once again published on this journal, showed a rate of CC in pre-pec IBBR cases followed by PMRT of 13.1% (11), suggesting that the adopted matrix played the key role. But, regarding this topic, Sinnott (9) found that the contracture rates were three times higher in the retro-pectoral cases submitted to PMRT rather than the pre-pec ones equally submitted to PMRT. This result points out a quite easy hypothesis, that the muscle coverage of the implant is the real difference and not the acellular dermal matrix use, as suggested by the aforementioned study by Graziano (11). At this regard, the aforementioned study of Sobti (8) clearly states: “we found that the difference in CC rates among position of implant groups was statistically significant”. So, it seems that the lower rates of CC in pre-pec cases are due to the absence of muscle over the implant rather than to the use of ADMs, also because similar low rates of CC in pre-pec cases have been described using synthetic meshes as well, even in the setting of PMRT (12,13).

Moreover, RT effect in the CC rate of pre-pec cases is maintained even in the setting of pre-mastectomy RT (14). Thus, it seems that there are two main factors involved in the CC process, namely RT and the implant position. But, since CC of pre-pec cases, no matter which mesh is adopted, is mostly induced by RT, either pre- or post-mastectomy, we could possibly argue that this is a particular type of fibrosis and a peculiar type of CC, which could be preferably considered as a separate entity, according to a specific paper on this issue (15). Similarly, in a very recent study from my institution, we found that RT related CC has specific histological features (16).

On the other hand, there are a lot of CCs not related to RT, once again with a striking prevalence in the retro-pectoral cases, as reported by a recent meta-analysis (17), showing that the muscle must be an independent key factor.

Moreover, to clearly highlight the key-role of the muscle, there is most often another drawback accompanying CC, such as “the animation deformity”. This phenomenon is never described or seen in a pre-pectoral reconstruction. Hence, a reasonable implication is that being CC dramatically reduced in a pre-pec IBBR, along with animation deformities, the CC we are often facing in IBBR could be due to a mechanical process. This process entails a constant shearing force, between the implant and the muscle, which is obviously higher in a retro-pectoral IBBR, where the force comes from above the implant with a constant crushing effect, rather than in a pre-pec setting. Nonetheless, a shearing force is obviously present in pre-pec IBBRs as well, since the mesh covering the implant, which will become the capsule, is always secured and fixed to the muscle, thus receiving a thrust from behind, anytime the muscle contracts and giving a slight movement to the implant even if it is placed in front of it. This might explain the very low CC rate in pre-pec patients in the absence of PMRT. Anyhow, there must be some other factor, in a multifactorial process, to explain why some patients develop CC while the majority don’t.

Another suggestion that might corroborate this hypothesis is related to a novel technical modification, which I personally described on this journal in 2017 (18) and which has been reported by other authors as well afterwards (19-22). This is the denervation of pectoralis major muscle in case of a retro-pectoral approach. Indeed, not all patients are good candidates to a pre-pec IBBR, and a retro-pectoral technique is still a safe and sound option for many patients with specific risk factors. Performing a muscular denervation, during the retro-pectoral pocket dissection, is a quite easy maneuver aimed to avoid the aforementioned animation deformities. As a consequence, a more natural ptosis of the reconstructed breast, which resembles a pre-pec IBBR, is obtained. But, most of all, this technical “trick” can really make the difference in case of a revising surgery done for a long-standing CC (18,22). Capsulectomy and implant changing are not always the solution and might be temporary, while pectoralis major muscle denervation allows an immediate and promising solution with a rewarding feeling for the patient and surgeon together. The rationale of such a procedure relies in avoiding the detrimental effect of the muscular constant movement over the implant. In fact, once the muscle has been detached from its sternal and costal attachments, its functionality becomes definitively compromised, while its viability is still essential to keep a vascularized cushion over the implant. Therefore, a denervation, obtained by means of selective neurotomies, maintains the muscle viable while paralyzing its lower two thirds, the sternal and costal bundles (18). Obviously, an atrophy will follow and will lessen the thickness of the muscle itself to reduce it almost to an autologous biological matrix.

In conclusion, in the tough choice of the “capsular contracture dilemma” there are two important clues: the pre-pec IBBR long-term impressive result in terms of low rates of CC and the pectoralis major muscle denervation as an encouraging approach to prevent and treat long-standing CC and for the avoidance of animation deformities. We could, hence, say that we are almost close to identify the real reason that causes CC, namely a continuous, never-stopping and ominous muscular contracture of the pectoralis major muscle against the breast implant capsule. Therefore, we could solve the dilemma by saying: not use the muscle when possible or, as an alternative, selectively denervate it when the muscle is necessary!


Acknowledgments

Funding: None.


Footnote

Peer Review File: Available at https://dx.doi.org/10.21037/gs-21-237

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/gs-21-237). The author has no conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Casella D, Calabrese C, Orzalesi L, et al. Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period. Breast Cancer 2017;24:451-7. [Crossref] [PubMed]
  2. American Society of Plastic Surgeons Statistics. Available online: https://www.plasticsurgery.org/documents/News/ Statistics/2019/plastic-surgery-statistics-full-report-2019.pdf
  3. O'Halloran N, Potter S, Kerin M, et al. Recent Advances and Future Directions in Postmastectomy Breast Reconstruction. Breast Cancer 2018;18:e571-85. [PubMed]
  4. Loreti A, Siri G, De Carli M, et al. Immediate Breast Reconstruction after mastectomy with polyurethane implants versus textured implants: A retrospective study with focus on capsular contracture. Breast 2020;54:127-32. [Crossref] [PubMed]
  5. Headon H, Kasem A, Mokbel K. Capsular contracture after breast augmentation: an update for clinical practice. Arch Plast Surg 2015;42:532-43. [Crossref] [PubMed]
  6. Hammond JB, Kosiorek HE, Cronin PA, et al. Capsular contracture in the modern era: A multidisciplinary look at the incidence and risk factors after mastectomy and implant-based breast reconstruction. Am J Surg 2021;221:1005-10. [Crossref] [PubMed]
  7. Chatterjee A, Nahabedian MY, Gabriel A, et al. Early assessment of post-surgical outcomes with pre-pectoral breast reconstruction: A literature review and meta-analysis. J Surg Oncol 2018;117:1119-30. [Crossref] [PubMed]
  8. Sobti N, Weitzman RE, Nealon KP, et al. Evaluation of capsular contracture following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction. Sci Rep 2020;10:1137. [Crossref] [PubMed]
  9. Sinnott CJ, Persing SM, Pronovost M, et al. Impact of Postmastectomy Radiation Therapy in Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction. Ann Surg Oncol 2018;25:2899-908. [Crossref] [PubMed]
  10. Polotto S, Bergamini ML, Pedrazzi G, et al. One-step prepectoral breast reconstruction with porcine dermal matrix-covered implant: a protective technique improving the outcome in post-mastectomy radiation therapy setting. Gland Surg 2020;9:219-28. [Crossref] [PubMed]
  11. Graziano FD, Shay PL, Sanati-Mehrizy P, et al. Prepectoral implant reconstruction in the setting of post-mastectomy radiation. Gland Surg 2021;10:411-6. [Crossref] [PubMed]
  12. Bernini M, Calabrese C, Cecconi L, et al. Subcutaneous Direct-to-Implant Breast Reconstruction: Surgical, Functional, and Aesthetic Results after Long-Term Follow-Up. Plast Reconstr Surg Glob Open 2016;3:e574 [Crossref] [PubMed]
  13. Casella D, Di Taranto G, Marcasciano M, et al. Evaluation of Prepectoral Implant Placement and Complete Coverage with TiLoop Bra Mesh for Breast Reconstruction: A Prospective Study on Long-Term and Patient-Reported BREAST-Q Outcomes. Plast Reconstr Surg 2019;143:1e-9e. [Crossref] [PubMed]
  14. Sinnott CJ, Pronovost MT, Persing SM, et al. The Impact of Premastectomy Versus Postmastectomy Radiation Therapy on Outcomes in Prepectoral Implant-Based Breast Reconstruction. Ann Plast Surg 2021;87:S21-7. [PubMed]
  15. Lipa JE, Qiu W, Huang N, et al. Pathogenesis of radiation-induced capsular contracture in tissue expander and implant breast reconstruction. Plast Reconstr Surg 2010;125:437-45. [Crossref] [PubMed]
  16. Gentile P, Bernini M, Orzalesi L, et al. Titanium-coated polypropylene mesh as innovative bioactive material in conservatives mastectomies and pre-pectoral breast reconstruction. Bioact Mater 2021;6:4640-53. [Crossref] [PubMed]
  17. Li Y, Xu G, Yu N, et al. Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Meta-analysis. Ann Plast Surg 2020;85:437-47. [Crossref] [PubMed]
  18. Bernini M, Casella D, Mariotti C. Selective pectoralis major muscle denervation in brea-st reconstruction: a technical modification for more effective and cosmetic results. Gland Surg 2017;6:745-50. [Crossref] [PubMed]
  19. Eck DL, Nguyen DC, Barnes LL, et al. Treatment of Breast Animation Deformity in Implant-Based Reconstruction with Selective Nerve Ablation. Aesthetic Plast Surg 2018;42:1472-5. [Crossref] [PubMed]
  20. Mamsen FP, Carstensen LF. Hyperspasticity After Partial Neurectomy for Treatment of Myospasms Following Subpectoral Breast Reconstruction. Plast Reconstr Surg Glob Open 2019;7:e2278 [Crossref] [PubMed]
  21. Engels PE, Kappos EA, Sieber PK, et al. From Bedside to Bench: The Effect of Muscular Denervation on Fat Grafting to the Breast by Comparing Take Rate, Quality, and Longevity. Aesthet Surg J 2018;38:900-10. [Crossref] [PubMed]
  22. Casella D, Lo Torto F, Marcasciano M, et al. Breast Animation Deformity: A Retrospective Study on Long-Term and Patient-Reported Breast-Q Outcomes. Ann Plast Surg 2021;86:512-6. [Crossref] [PubMed]
Cite this article as: Bernini M. “To use or not to use the muscle” that is the question in the capsular contracture dilemma. Gland Surg 2021;10(7):2084-2087. doi: 10.21037/gs-21-237

Download Citation